Integrating Molecular and Imaging Insights: Ryanodine Receptor 2 (RyR2) Expression, CK18 Status, and Conventional MRI Findings in Pituitary Neuroendocrine Tumors.

Duseikaite-Vidike M, Vilkeviciute-Petraite A, Zostautiene I, Kasetaite V, Urbonaite A, Zaliunas BR, Poskiene L, Makstiene J, Wu SN, Rovite V, Mandrika I, Tamasauskas A, Liutkeviciene R

Open source

DOI
10.3390/ijms27188146
Published
2026 Sep 12
Container
International journal of molecular sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms27188146,
  title = {Integrating Molecular and Imaging Insights: Ryanodine Receptor 2 (RyR2) Expression, CK18 Status, and Conventional MRI Findings in Pituitary Neuroendocrine Tumors.},
  author = {Duseikaite-Vidike M and Vilkeviciute-Petraite A and Zostautiene I and Kasetaite V and Urbonaite A and Zaliunas BR and Poskiene L and Makstiene J and Wu SN and Rovite V and Mandrika I and Tamasauskas A and Liutkeviciene R},
  year = {2026},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms27188146},
  url = {https://doi.org/10.3390/ijms27188146}
}

RIS

TY  - JOUR
TI  - Integrating Molecular and Imaging Insights: Ryanodine Receptor 2 (RyR2) Expression, CK18 Status, and Conventional MRI Findings in Pituitary Neuroendocrine Tumors.
AU  - Duseikaite-Vidike M
AU  - Vilkeviciute-Petraite A
AU  - Zostautiene I
AU  - Kasetaite V
AU  - Urbonaite A
AU  - Zaliunas BR
AU  - Poskiene L
AU  - Makstiene J
AU  - Wu SN
AU  - Rovite V
AU  - Mandrika I
AU  - Tamasauskas A
AU  - Liutkeviciene R
PY  - 2026
JO  - International journal of molecular sciences
DO  - 10.3390/ijms27188146
UR  - https://doi.org/10.3390/ijms27188146
ER  - 

APA

M, D., A, V., I, Z., V, K., A, U., BR, Z., L, P., J, M., SN, W., V, R., I, M., A, T., & R, L. (2026). Integrating Molecular and Imaging Insights: Ryanodine Receptor 2 (RyR2) Expression, CK18 Status, and Conventional MRI Findings in Pituitary Neuroendocrine Tumors.. International journal of molecular sciences. https://doi.org/10.3390/ijms27188146

Source records